Literature DB >> 15627823

Quantification of blood-aqueous barrier breakdown after phacoemulsification in Fuchs' heterochromic uveitis.

Nhung X Nguyen1, Michael Kuchle, Gottfried O H Naumann.   

Abstract

PURPOSE: To quantify the breakdown of the blood-aqueous barrier (BAB) following phacoemulsification with posterior chamber lens implantation in eyes with Fuchs' heterochromic uveitis (FHU). PATIENTS AND METHODS: In this retrospective study, 19 eyes of 19 patients with FHU (mean age 38 +/- 14 years) and 35 eyes of 35 patients with senile cataracts (mean age 63 +/- 9 years) underwent phacoemulsification with one-piece PMMA posterior chamber lens implantation. Aqueous flare was quantified using the laser flare-cell meter (LFCM, Kowa FC-1000) following medical pupillary dilation preoperatively and 1, 3, and 5 days, then 1 and 6 weeks and 6 months postoperatively.
RESULTS: Mean preoperative aqueous flare (in photon counts per millisecond) in FHU vs. controls was 11.7 +/- 3.5 vs. 5.8 +/- 1.7. Following cataract surgery, mean aqueous flare increased to 27.8 +/- 4.4 vs. 16.0 +/- 4.5 on day 1, decreased to 23.6 +/- 4.0 vs. 11.8 +/- 3.5 on day 3, and to 18.0 +/- 3.0 vs. 9.5 +/- 1.7 on day 5. In FHU eyes, it was 13.9 +/- 2.7 after 1 week, and had returned to preoperative levels after 6 weeks (10.9 +/- 2.5) and remained stable for up to 6 months (mean 10.3 +/- 2.2). Pre- and postoperatively, aqueous flare values were 2-3 times higher in FHU eyes than in control eyes with senile cataract (p = 0.01). No postoperative complications such as fibrin formation, synechiae, macrophages on the intraocular lens optic or endophthalmitis were observed in any of the patients.
CONCLUSIONS: BAB breakdown following phacoemulsification with posterior chamber lens implantation is relatively mild in eyes with FHU and the BAB appears to be fully reestablished to preoperative levels 6 weeks postoperatively, explaining the usually good outcome of cataract surgery in this condition. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15627823     DOI: 10.1159/000081778

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  7 in total

Review 1.  Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation.

Authors:  Ilknur Tugal-Tutkun; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2009-05-09       Impact factor: 2.031

2.  Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behcet's disease.

Authors:  Peizeng Yang; Wang Fang; Xiangkun Huang; Hongyan Zhou; Li Wang; Bo Jiang
Journal:  Int Ophthalmol       Date:  2008-05-15       Impact factor: 2.031

Review 3.  Laser flare-cell photometer: principle and significance in clinical and basic ophthalmology.

Authors:  Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2016-11-25       Impact factor: 2.447

4.  Fuchs' Uveitis: Failure to Associate Vitritis and Disc Hyperfluorescence with the Disease is the Major Factor for Misdiagnosis and Diagnostic Delay.

Authors:  Nadia Bouchenaki; Carl P Herbort
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

5.  Early Ophthalmic Artery Blood Flow Parameter Changes in Patients with Type 1 Diabetes Mellitus.

Authors:  Serdar Ozates; Betul Emine Derinkuyu; Ufuk Elgin; Meliksah Keskin; Nursel Muratoglu Sahin; Zehra Aycan
Journal:  Beyoglu Eye J       Date:  2020-02-14

Review 6.  Research Progress on the Mechanism of Natural Product Ingredients in the Treatment of Uveitis.

Authors:  Sicong Li; Fang Liu; Kai Zhang; Yujia Tong; Xin Liu
Journal:  J Immunol Res       Date:  2021-07-16       Impact factor: 4.818

7.  Aqueous humor erythropoietin levels in open-angle glaucoma patients with and without TTR V30M familial amyloid polyneuropathy.

Authors:  João M Beirão; Luciana M Moreira; João C Oliveira; Maria J Menéres; Bernardete B Pessoa; Maria E Matos; Paulo P Costa; Paulo A Torres; Idalina B Beirão
Journal:  Mol Vis       Date:  2014-07-02       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.